The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
Cancer Research - United States
doi 10.1158/0008-5472.can-15-1070
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2015
Authors
Publisher
American Association for Cancer Research (AACR)